The Changing Epidemiology of Vancomycin-Resistant Enterococcus (VRE) Bacteremia in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
Open Access
- 30 November 2010
- journal article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 16 (11), 1576-1581
- https://doi.org/10.1016/j.bbmt.2010.05.008
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
This publication has 24 references indexed in Scilit:
- Hematologic Safety Profile of Linezolid in the Early Periengraftment Period after Allogeneic Stem Cell TransplantationTransplantation and Cellular Therapy, 2009
- Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspectiveBone Marrow Transplantation, 2009
- Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficitsNature, 2008
- Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipientsBone Marrow Transplantation, 2007
- Vancomycin‐resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high‐riskEuropean Journal of Haematology, 2007
- Nosocomial Spread of Linezolid-Resistant, Vancomycin-ResistantEnterococcus faeciumThe New England Journal of Medicine, 2002
- High Rate of False‐Negative Results of the Rectal Swab Culture Method in Detection of Gastrointestinal Colonization with Vancomycin‐Resistant EnterococciClinical Infectious Diseases, 2002
- The Effect of Vancomycin and Third-Generation Cephalosporins on Prevalence of Vancomycin-Resistant Enterococci in 126 U.S. Adult Intensive Care UnitsAnnals of Internal Medicine, 2001
- Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolidThe Lancet, 2001
- Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantationBone Marrow Transplantation, 2000